Movatterモバイル変換

[0]ホーム
URL:

Pershad et al., 2010 - Google Patents

Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display

Pershad et al., 2010

ViewHTML
Document ID
11512917187702173074
Author
Pershad K
Pavlovic J
Gräslund S
Nilsson P
Colwill K
Karatt-Vellatt A
Schofield D
Dyson M
Pawson T
Kay B
McCafferty J
Publication year
Publication venue
Protein Engineering, Design & Selection

External Links

Snippet

To demonstrate the utility of phage display in generating highly specific antibodies, affinity selections were conducted on 20 related Src Homology 2 (SH2) domains (ABL1, ABL2, BTK, BCAR3, CRK, FYN, GRB2, GRAP2, LYN, LCK, NCK1, PTPN11 C, PIK3R1 C, PLCγ1 C …
Continue reading atacademic.oup.com (HTML) (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

PublicationPublication DateTitle
Pershad et al.Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display
Holt et al.By-passing selection: direct screening for antibody–antigen interactions using protein arrays
Colwill et al.A roadmap to generate renewable protein binders to the human proteome
Yonezawa et al.DNA display for in vitro selection of diverse peptide libraries
Varadamsetty et al.Designed Armadillo repeat proteins: library generation, characterization and selection of peptide binders with high specificity
Qiang et al.Discovery of a polystyrene binding peptide isolated from phage display library and its application in peptide immobilization
Sjöberg et al.Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling
Karatan et al.Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain
US8592179B2 (en)Artificial binding proteins based on a modified alpha helical region of ubiquitin
UhlénAffinity as a tool in life science
Bradbury et al.Antibodies in proteomics II: screening, high-throughput characterization and downstream applications
Säll et al.Generation and analyses of human synthetic antibody libraries and their application for protein microarrays
Di Niro et al.Rapid interactome profiling by massive sequencing
Freund et al.Reconstitution of the receptor-binding motif of the SARS coronavirus
Traxlmayr et al.Construction of pH‐sensitive Her2‐binding IgG1‐Fc by directed evolution
Olson et al.mRNA display selection of a high-affinity, modification-specific phospho-IκBα-binding fibronectin
Ernst et al.Rapid evolution of functional complexity in a domain family
Rojas et al.High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surface
Waraho et al.Versatile selection technology for intracellular protein–protein interactions mediated by a unique bacterial hitchhiker transport mechanism
Miller et al.Beyond epitope binning: directed in vitro selection of complementary pairs of binding proteins
Du et al.mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1
Murray et al.Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2
Karlsson et al.Improved affinity at the cost of decreased specificity: a recurring theme in PDZ-peptide interactions
Hajikarimlou et al.A computational approach to rapidly design peptides that detect SARS-CoV-2 surface protein S
Taussig et al.Development of proteome‐wide binding reagents for research and diagnostics
[8]ページ先頭
©2009-2025 Movatter.jp